Skip to content

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

European researchers develop method of calculating short-term risk of HIV disease progression

T-20 increases tipranavir levels but does not increase risk of liver side-effects

Virologically failing NNRTI regimens have higher resistance risk than failing boosted-PIs

Cognitive impairment common in people with HIV despite antiretroviral therapy

First-line treatment choices proving challenging for African ART programmes

WHO to monitor ARV side-effects worldwide

Pillboxes should be standard issue for HIV patients, study concludes

Switch to nevirapine safe for treatment-experienced patients with high CD4 cell counts